Safety reports

BlueReg has extensive experience in writing safety documents in a wide variety of settings and different stages of the product lifecycle.

 

The experienced team can support with assessing a product risk benefit profile and writing a Risk Management Plan (RMP), Development Safety Update Report (DSUR), Periodic Benefit-Risk Evaluation Report  (PBRER) and early access reports. Furthermore, BlueReg can provide support to update the Summary of Product Characteristics (SmPC) for safety reasons.

 

All these activities are carried out in full compliance with Good Vigilance Practices and local standards.

Our experts

Associated News

The French system for preventing and managing shortages

The French regulation on the prevention and management of stock shortages of medicinal products is...

Learn more

New Appointment to our Leadership Team !

BlueReg Group is delighted to announce the appointment of Dominique Patrone as General Manager of PharmaBlue....

Learn more

EMA GUIDANCE – COVID-19

Given the support given to our clients in interactions with health authorities all around the...

Learn more

Register Now for our Next BlueReg Webinar !